why choose us

Clinical Trials Search

Showing 14,090 of 132,366 result(s)
Safety, Tolerability and Efficacy of AntiBKV as Treatment of BKV Infection in Kidney Transplant Recipients

Status: Completed

Condition: BK Viremia; BKV DNAemia

Interventions: Participants in the study arm will each receive 4 doses (1,000 mg) administered at 4 weekly intervals administered on Days 1, 29, 57 and 85.

Date: 2023-03-03

Cognitive Behavioral Therapy for Adolescents With Bulimia Nervosa and Higher Weight (Online Treatment Study)

Status: Completed

Condition: Bulimia Nervosa

Interventions: Cognitive Behavioral Therapy (CBT) is a psychological treatment or "talk therapy" that integrates how people think, feel, and behave to crea

Date: 2023-03-03

Medically Intensive Nutrition Therapy Program for Obesity and Diabetes in a Low-income Population

Status: Completed

Condition: Overweight

Interventions: Meal replacement products offered through the Massachusetts General Hospital Weight Center.

Date: 2023-03-03

Identification of Treatment Concentrations of Defactinib or VS-6766 for the Treatment of Patients With Glioblastoma

Status: Completed

Condition: Glioblastoma

Interventions: Given PO

Date: 2023-03-03

Study of RO7515629 in Participants With HLA-G Positive Solid Tumors

Status: Completed

Condition: Renal Cell Carcinoma

Interventions: RO7515629 will be administered intravenously at a dose and schedule as specified for the respective study part and cohort.

Date: 2023-03-03

Setrusumab vs Bisphosphonates in Pediatric Subjects With Osteogenesis Imperfecta

Status: Completed

Condition: Osteogenesis Imperfecta

Interventions: Administered per investigator discretion via intravenous (IV) infusion

Date: 2023-03-03

Circulating Tumor DNA to Guide Changes in Standard of Care Chemotherapy

Status: Completed

Condition: Metastatic HER2-Negative Breast Carcinoma

Interventions: Undergo blood sample collection for banking

Date: 2023-03-03

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of RLS-0071 in Newborns With Moderate or Severe Hypoxic-Ischemic Encephalopathy Undergoing Therapeutic Hypothermia

Status: Completed

Condition: Hypoxic-Ischemic Encephalopathy

Interventions: RLS-0071 (unit strength 10 mg;mL) will be administered by infusion for a dose level of 3, 10, or 20 mg;kg.
Planned infusion duration is

Date: 2023-03-03

Interaction of CYP2B6 Genotype and Efavirenz With Methadone and Tizanidine PK

Status: Completed

Condition: Drug-Drug Interaction

Interventions: Each CYP2B6 genotype predicted phenotypes will receive methadone (10 mg) and tizanidine (4 mg) by mouth at baseline (control)

Date: 2023-03-03

A Retrospective Study to Characterize Participants With Propionic Acidemia

Status: Completed

Condition: Propionic Acidemia

Interventions:

Date: 2023-03-03